In 2024, healthcare venture capital investments reached $23 billion, a $3 billion increase from the previous year, driven by the rise of artificial intelligence (AI) in the sector, according to Silicon Valley Bank. Biopharma AI attracted over $5 billion, a 300% surge from 2023, with large deals dominating. Early-stage investments rose, with 40% of deals in seed rounds, 35% of which involved AI. Established healthtech firms drew significant funding, while startups face pressure to prove value. The report anticipates steady growth in various healthcare sectors but notes subdued IPO activity as markets stabilize.